P53 Alignment between CDA recommendations and pCPA negotiation outcomes: exploring factors influencing reimbursement success
Zaitceva, V., Eaves, K., Mills, M. & Kanavos, P.
(2025).
P53 Alignment between CDA recommendations and pCPA negotiation outcomes: exploring factors influencing reimbursement success.
Value in Health,
28(6, Supplement 1), S19.
https://doi.org/10.1016/j.jval.2025.04.071
(2025).
P53 Alignment between CDA recommendations and pCPA negotiation outcomes: exploring factors influencing reimbursement success.
Value in Health,
28(6, Supplement 1), S19.
https://doi.org/10.1016/j.jval.2025.04.071
This study assesses the alignment between Canadian Drug Agency (CDA) reimbursement recommendations and pan-Canadian Pharmaceutical Alliance (pCPA) negotiation outcomes. It examines factors contributing to failures in pricing negotiations for drugs considered to provide sufficient value to the Canadian healthcare system.